We are live on ! Find out more
JJ

Johnson & Johnson Portfolio holdings

AUM $799M
1-Year Est. Return 253.51%
This Fund
S&P 500
This Quarter Est. Return
+24.35%
1 Year Est. Return
+253.51%
3 Year Est. Return
+280.64%
5 Year Est. Return
+320.83%
10 Year Est. Return
–
AUM
$799M
AUM Growth
+$146M
Cap. Flow
+$11.1M
Cap. Flow %
1.38%
Top 10 Hldgs %
98.41%
Holding
17
New
1
Increased
–
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
CBRS
Cerebras Systems
CBRS
+$12.6M

Top Sells

Rank Stock Value
1
RLYB icon
Rallybio
RLYB
+$1.37M
2
NNOX icon
Nano X Imaging
NNOX
+$190K

Sector Composition

Rank Sector Weight
1 Healthcare 98.52%
2 Technology 1.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
1
Protagonist Therapeutics
PTGX
$9.63B
$300M 37.59%
2,449,183
– –
NBTX
2
Nanobiotix
NBTX
$2.03B
$212M 26.55%
5,623,816
– –
MGTX icon
3
MeiraGTx Holdings
MGTX
$1.34B
$89.7M 11.23%
6,641,064
– –
RAPP
4
Rapport Therapeutics
RAPP
$2.29B
$74.4M 9.31%
1,784,517
– –
CTNM
5
Contineum Therapeutics
CTNM
$661M
$32.4M 4.06%
1,979,173
– –
LEGN icon
6
Legend Biotech
LEGN
$4.23B
$23.5M 2.95%
814,586
– –
CVRX icon
7
CVRx
CVRX
$80.2M
$20.7M 2.59%
4,024,861
– –
XNCR icon
8
Xencor
XNCR
$1.98B
$12M 1.51%
748,062
– –
CBRS
9
Cerebras Systems
CBRS
$45.2B
$11.8M 1.48%
+53,586
New +$12.6M
FATE icon
10
Fate Therapeutics
FATE
$290M
$9.12M 1.14%
3,379,064
– –
PRCT icon
11
Procept Biorobotics
PRCT
$1.22B
$8.08M 1.01%
357,939
– –
NMRA icon
12
Neumora Therapeutics
NMRA
$254M
$3.14M 0.39%
1,849,445
– –
VOR icon
13
Vor Biopharma
VOR
$1.43B
$989K 0.12%
53,732
– –
LAB icon
14
Standard BioTools
LAB
$265M
$257K 0.03%
311,967
– –
ACET icon
15
Adicet Bio
ACET
$88.3M
$197K 0.02%
22,779
– –
NNOX icon
16
Nano X Imaging
NNOX
$56M
– –
-83,554
Closed -$190K
RLYB icon
17
Rallybio
RLYB
$89.6M
– –
-152,901
Closed -$1.37M

Similar funds

SEM
Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return
TI
TrueMark Investments Chicago, Illinois $798M AUM 25.52% 1-Year Est. Return
GIM
Garden Investment Management Greenwich, Connecticut $798M AUM 18.61% 1-Year Est. Return
QCMNJ
Quantum Capital Management (New Jersey) Northfield, New Jersey $798M AUM 8.86% 1-Year Est. Return
LOPW
Live Oak Private Wealth Wilmington, North Carolina $800M AUM 24.59% 1-Year Est. Return
HW
HORAN Wealth Cincinnati, Ohio $800M AUM 23.65% 1-Year Est. Return
XPN
XY Planning Network Bozeman, Montana $797M AUM 18.89% 1-Year Est. Return
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return

Johnson & Johnson's Q2 2026 Portfolio in Review

As of Q2 2026, Johnson & Johnson held 17 positions worth $799M, up 22% from $652M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Johnson & Johnson's Q2 2026 filing shows 1 new and 2 closed positions. Its largest new stake was Cerebras Systems: 53,586 shares worth $11.8M. The largest sale was Rallybio, an estimated $1.37M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Technology.

  • Johnson & Johnson's largest Q2 2026 buy was Cerebras Systems: 53,586 shares worth $11.8M.
  • Johnson & Johnson fully exited Rallybio in Q2 2026, selling an estimated $1.37M.
  • Johnson & Johnson's ten largest holdings make up 98% of its $799M portfolio in Q2 2026.
  • Johnson & Johnson opened 1 new position and closed 2 in Q2 2026.
  • Johnson & Johnson's portfolio value rose 22% quarter-over-quarter to $799M.

Based on Johnson & Johnson's 13F filing for Q2 2026, filed 6 Aug 2026.